LyondellBasell to Discuss Second Quarter Results on Friday, July 29, 2022 July 15, 2022 6:30 am|HOUSTON and LONDON, July 15, 2022 /PRNewswire/ — LyondellBasell (NYSE: LYB), a leader in the global chemistry industry,…
Canadian Nuclear Safety Commission Approves NexGen Draft EIS to Proceed to Technical Review July 15, 2022 6:30 am|VANCOUVER, BC, July 15, 2022 /PRNewswire/ – NexGen Energy Ltd. (“NexGen” or the “Company”) (TSX: NXE) (NYSE: NXE) (ASX:…
Griner lawyer: WNBA star had doctor’s letter for cannabis July 15, 2022 6:29 am|KHIMKI, Russia (AP) — A lawyer for WNBA star Brittney Griner on Friday, who is jailed in Russia…
Sandvik: Interim report second quarter 2022 July 15, 2022 6:19 am|STOCKHOLM, July 15, 2022 /PRNewswire/ —
Ukrainian rescue teams hunt for survivors in Vinnytsia July 15, 2022 6:14 am|VINNYTSIA, Ukraine (AP) — Rescue teams with sniffer dogs combed through debris in a central Ukrainian city on…
Baidu to Reveal Latest Updates for Autonomous Driving, AI Cloud, Large AI Model at Baidu World 2022 July 15, 2022 6:13 am|BEIJING, July 15, 2022 /PRNewswire/ — Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888), a leading AI company with strong Internet foundation,…
Tencent Music Entertainment Group to Report Second Quarter 2022 Financial Results on August 15, 2022 Eastern Time July 15, 2022 6:00 am|SHENZHEN, China, July 15, 2022 /PRNewswire/ — Tencent Music Entertainment Group (“TME”, or the “Company”) (NYSE: TME), the leading online…
New survey shows parents are highly concerned about their ability to protect childrens' personal data, want Congress to prioritize adopting additional privacy protections July 15, 2022 6:00 am|WASHINGTON, July 15, 2022 /PRNewswire/ — Trusted Future today released the results of a survey of nearly 1,000…
XT.com Lists PROJECT202 (P202) With USDT Trading Pair July 15, 2022 6:00 am|SINGAPORE, July 15, 2022 /PRNewswire/ — The PROJECT202 (P202) token will soon be listed on XT.com as the P202…
Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML) July 15, 2022 6:00 am|Escend announces IND clearance for ES-3000 phase I study in relapsed or refractory (R/R) acute myeloid leukemia (AML)